WuXi To Benefit from Global Outsourcing - China

One look at a Chinese Drug company and who their large outsources clients are here in the US…names we all recognize too. Add the 3 numbers up and you come up with around 38% of their business from the 3 companies. The number of blockbuster drugs going off patent along with the rising R&D costs are opening the floodgates for offshore outsourcing with big Pharma today, so how much is really still manufactured here in the US? BD

BEIJING - WuXi PharmaTech is positioning itself to ride the rising tides of global pharmaceutical outsourcing to strengthen its role as China's largest contract research organization, according to a WuXi executive and an independent analyst.

WuXi's three largest customers in 2007 were Pfizer, Merck and Vertex Pharmaceuticals, which accounted for 15 percent, 12.2 percent, and 11.2 percent of the company's net revenues in 2007, respectively, the filing noted.